Bilateral vs. unilateral electrode configurations in electroconvulsive therapy — how placement shapes current pathway, speed of response, and cognitive side-effect burden
Electroconvulsive therapy delivers a brief, controlled electrical stimulus through scalp electrodes to induce a generalized therapeutic seizure. Where those electrodes sit on the head determines the geometry of the current pathway through the brain — and that geometry is one of the central levers clinicians use to balance speed of antidepressant response against cognitive side effects. Three configurations dominate modern practice: bitemporal bilateral, bifrontal bilateral, and right unilateral (RUL).
In bitemporal bilateral placement, one electrode is positioned over each temple, roughly at the midpoint between the outer corner of the eye and the external ear canal on each side. Current flows directly across the skull between the two electrodes, passing through both cerebral hemispheres including deep midline structures. This was the original ECT configuration and remains the most extensively studied.
Because the current field is wide and bilateral, bitemporal placement reliably produces a generalized seizure at relatively low stimulus doses (typically around 1.5x the individually titrated seizure threshold). It is generally regarded as producing the most consistently rapid symptom improvement of the three placements — a relevant consideration when illness severity or urgency (e.g., acute suicidality, catatonia, or psychotic depression) argues for the fastest available treatment effect.
Bifrontal placement moves both electrodes forward, to the frontal region above each eyebrow. It remains bilateral (current still crosses the midline) but the field is narrower and more anteriorly concentrated than bitemporal, sparing more of the temporal-lobe memory circuitry that is thought to underlie much of ECT-related retrograde amnesia.
Right unilateral placement is the most anatomically distinct option: both electrodes are placed over the right hemisphere only — one temporal, one further forward or toward the vertex — so the stimulus never has to bridge the midline to produce a generalized seizure. Because the right hemisphere is nondominant for language and verbal memory in the great majority of people, this placement is associated with a substantially lower burden of the anterograde and retrograde memory effects that are the most disliked side effect of ECT.
When both electrodes sit on opposite sides of the head — bitemporal or bifrontal — the electrical stimulus must cross the interhemispheric midline to complete its circuit. The resulting current field sweeps through cortical and subcortical structures on both sides simultaneously, including bilateral prefrontal cortex, bilateral temporal-limbic circuitry, and diencephalic structures thought to be central to ECT's antidepressant mechanism.
Seizure generalization — the spread of synchronized electrical activity throughout the whole brain, not just a local region — is what produces ECT's therapeutic effect, not the local tissue directly beneath the electrodes. Bilateral placements achieve robust, symmetric generalization at a low relative dose because the stimulus is already delivered across both hemispheres from the outset.
Clinical and meta-analytic evidence has generally found that bitemporal ECT produces the fastest average time-to-response among the standard placements, which is one reason it continues to be favored in situations where speed of improvement is a priority in its own right — for example, severe melancholic or psychotic depression, high suicide risk, or catatonia requiring urgent symptom control.
The same wide current field that speeds symptom relief also passes directly through medial temporal-lobe structures on both sides that are heavily involved in memory consolidation and retrieval. This is the leading explanation for why bilateral placements — bitemporal more than bifrontal — carry a comparatively higher risk of anterograde memory difficulty (trouble learning new information around the time of treatment) and retrograde amnesia (gaps for memories formed before or during the treatment course, most pronounced for autobiographical and recent events).
Bifrontal placement is often framed as a partial answer to this trade-off: still bilateral (and so still expected to generalize efficiently), but angled away from the temporal lobes, which several trials suggest may reduce — without eliminating — the cognitive burden relative to bitemporal, while keeping efficacy in a broadly similar range.
Right unilateral (RUL) placement puts both electrodes on the same side of the head, over the hemisphere that is nondominant for language and verbal memory in most people. Because the circuit never has to cross the midline in the same direct way, the induced current can, in principle, remain more confined to one side — sparing dominant-hemisphere verbal memory circuitry that appears to be especially vulnerable to ECT-related cognitive effects.
A key finding that shaped modern unilateral ECT practice is that its efficacy is far more sensitive to stimulus dose than bilateral placement's efficacy is. At doses only modestly above an individual's seizure threshold, RUL can generalize a seizure but produce comparatively weak antidepressant effects. Landmark dose-titration research found that raising the relative dose well above threshold — commonly framed as roughly five to six times the seizure threshold — substantially closes the efficacy gap with bilateral placement, while the cognitive-sparing advantage of staying on one hemisphere is largely retained.
This is why the "relative stimulus dose" control in this simulator has an outsized effect specifically on unilateral outcomes: bilateral placements are already close to their efficacy ceiling at low relative doses, whereas unilateral placement genuinely needs the extra energy to recruit an equivalently effective seizure.
Verbal memory encoding and retrieval are lateralized predominantly to the left hemisphere in the large majority of people (including most left-handed individuals). By concentrating the current field on the right hemisphere, RUL is thought to spare much of the circuitry most implicated in the autobiographical and verbal memory complaints that patients most often report after ECT.
The practical consequence, reflected consistently across controlled comparisons, is that patients receiving right unilateral ECT — even at the higher doses required for full efficacy — tend to report and test with less anterograde and retrograde memory disruption than patients receiving bitemporal ECT. This does not mean RUL is cognitively inert: at very high doses, or in cognitively vulnerable patients, some memory effects can still occur.
No electrode placement dominates on every dimension. The recurring theme across the comparative ECT literature is a trade-off surface: placements that generalize a seizure efficiently across a broad bilateral field tend to relieve symptoms faster, at the cost of a heavier cognitive footprint; placements confined to one, nondominant hemisphere tend to spare cognition, at the cost of needing a higher relative dose and sometimes more sessions to reach comparable efficacy.
It is tempting to look for a single "best" placement, but the evidence base instead supports a trade-off frame: bitemporal placement sits at one end (fast, broadly effective, more cognitive cost), high-dose right unilateral sits toward the other end (typically a bit slower to reach full effect or requiring more sessions, but gentler cognitively), and bifrontal placement is commonly positioned as an intermediate compromise — broadly bilateral like bitemporal, but often better tolerated cognitively, with efficacy generally reported as similar to or only modestly below bitemporal in most comparative studies.
Meta-analyses of randomized comparisons have generally found that adequately dosed high-dose RUL and bitemporal ECT produce similar remission rates by the end of an acute treatment course, even though bitemporal often gets there somewhat faster — an important nuance for less urgent presentations, where the extra time to full response may be an acceptable exchange for a meaningfully lower cognitive burden.
Dose is not a free variable that only changes seizure likelihood — it interacts with placement on both axes of the trade-off. Pushing bilateral placements to very high relative doses adds little additional efficacy (they are already near ceiling at modest doses) but can add cognitive cost. Pushing unilateral placement to a higher relative dose meaningfully improves efficacy and is generally still associated with less cognitive burden than bilateral placement at its own effective dose — which is why high-dose RUL, rather than low-dose RUL, became the standard unilateral protocol in contemporary practice.
Electrode placement in ECT is a clinical decision made jointly by the treating team and the patient, weighing several factors that do not always point in the same direction. There is no placement that is correct by default; the decision pathway below reflects how clinicians commonly reason through the trade-off described in the previous stage.
When rapid symptom control is critical — severe melancholic or psychotic depression, high acute suicide risk, catatonia, or marked functional decline such as refusal of food or fluids — the faster average response associated with bitemporal (or, less commonly, bifrontal) bilateral placement can be weighed as clinically decisive, even accepting a greater cognitive side-effect burden as a reasonable exchange for urgent, reliable improvement.
A patient who has previously responded well to a specific placement, or who previously found one placement's cognitive effects intolerable, provides direct evidence that often outweighs population-level tendencies. Prior non-response to an adequately dosed unilateral course is a common reason to switch to bilateral placement in a subsequent course, and vice versa for patients who found bilateral cognitive effects too burdensome.
Older patients, those with pre-existing cognitive impairment or neurodegenerative disease, and those in occupations or life circumstances especially dependent on intact verbal memory are frequently steered toward right unilateral placement at an adequate dose to minimize added cognitive risk. At the same time, an informed patient's own preference — after being walked through this same speed-versus-cognition trade-off — is treated as a legitimate and often decisive input, not merely a formality.